Keywords: alexion, gains, rights, soliris-related, patents, 10m, pharmaceuticals

Alexion gains rights to Soliris-related patents for $10M

Article | 25 February 2008

Alexion Pharmaceuticals has agreed to acquire from fellow USA-based Oklahoma Medical Research Foundation all rights to certain patents related to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

eculizumab

Soliris

Go to drug listing